keyword
https://read.qxmd.com/read/35134273/nanoplatform-self-assembly-from-small-molecules-of-porphyrin-derivatives-for-nir-ii-fluorescence-imaging-guided-photothermal-immunotherapy
#41
JOURNAL ARTICLE
Yanbing Cao, De Wei, Lixia Yang, Zijin Luo, Peiwen Yu, Hao Li, Cao Zhang, Xiaolong Liu, Fengshou Wu, Ming Wu, Yongyi Zeng
Combinatorial photothermal and immunotherapy have demonstrated great potential to remove primary tumors, suppress metastases, and prevent tumor recurrence. However, this strategy still confronts with many limitations, such as complex components, sophisticated construction and inadequate therapeutic efficacy. In this work, we develop small molecules of porphyrin derivatives (PPor) which can self-assemble into monodispersed nanoparticles without supplement of any other ingredients or surfactants. The formed PPor nanoparticles (PPor NPs) exhibit highly photothermal conversion efficiency of 70% and NIR-II luminous abilities originated from the strong intramolecular charge transfer (ICT) effect of D-A structure under 808 nm laser irradiation, thus achieving NIR-II fluorescence imaging guided photothermal therapy (PTT) against primary tumor with a high cure rate...
February 8, 2022: Advanced Healthcare Materials
https://read.qxmd.com/read/35127391/light-controllable-charge-reversal-nanoparticles-with-polyinosinic-polycytidylic-acid-for-enhancing-immunotherapy-of-triple-negative-breast-cancer
#42
JOURNAL ARTICLE
Lei Fang, Zitong Zhao, Jue Wang, Ping Xiao, Xiangshi Sun, Yaping Ding, Pengcheng Zhang, Dangge Wang, Yaping Li
Nucleic acid drugs are highly applicable for cancer immunotherapy with promising therapeutic effects, while targeting delivery of these drugs to disease lesions remains challenging. Cationic polymeric nanoparticles have paved the way for efficient delivery of nucleic acid drugs, and achieved stimuli-responsive disassembly in tumor microenvironment (TME). However, TME is highly heterogeneous between individuals, and most nanocarriers lack active-control over the release of loaded nucleic acid drugs, which will definitely reduce the therapeutic efficacy...
January 2022: Acta Pharmaceutica Sinica. B
https://read.qxmd.com/read/35094188/tumor-infiltrating-lymphocytes-tils-as-a-biomarker-of-abscopal-effect-of-cryoablation-in-breast-cancer-a-pilot-study
#43
JOURNAL ARTICLE
Sonia Y Khan, Michael W Melkus, Fahmida Rasha, Maribel Castro, Victoria Chu, Luis Brandi, Hafiz Khan, Harvinder Singh Gill, Kevin Pruitt, Rakhshanda Layeequr Rahman
BACKGROUND: Morphological evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer is gaining momentum as an immunological biomarker. This experiment evaluates the role of TILs in distant tumors as a measure of abscopal effect from cryoablation of breast cancer. METHODS: BALB/c mice underwent bilateral orthotopic transplant with 4T1-12B (triple-negative) cells. At 2 weeks, left tumors were treated by either resection (standard of care group) or cryoablation (intervention group) followed by resection of the distant right tumors 1 week posttreatment...
May 2022: Annals of Surgical Oncology
https://read.qxmd.com/read/35076772/aso-visual-abstract-tumor-infiltrating-lymphocytes-tils-as-a-biomarker-of-abscopal-effect-of-cryoablation-in-breast-cancer-a-pilot-study
#44
JOURNAL ARTICLE
Sonia Y Khan, Michael W Melkus, Fahmida Rasha, Maribel Castro, Victoria Chu, Luis Brandi, Hafiz Khan, Harvinder Singh Gill, Kevin Pruitt, Rakhshanda Layeequr Rahman
No abstract text is available yet for this article.
January 25, 2022: Annals of Surgical Oncology
https://read.qxmd.com/read/34981675/engineered-mesenchymal-stem-cells-as-a-biotherapy-platform-for-targeted-photodynamic-immunotherapy-of-breast-cancer
#45
JOURNAL ARTICLE
Hanxi Zhang, Yi Feng, Xiaoxue Xie, Ting Song, Geng Yang, Qingqing Su, Tingting Li, Shun Li, Chunhui Wu, Fengming You, Yiyao Liu, Hong Yang
Interleukin-12 (IL12) is a pleiotropic cytokine with promising prospects for cancer immunotherapy. Though IL12 gene-based therapy can overcome the fatal hurdle of severe systemic toxicity, targeted delivery and tumor-located expression of IL12 gene remain the challenging issues yet to be solved. Photo-immunotherapy emerging as a novel and precise therapeutic strategy, which elaborately combines immune-activating agents with light-triggered photosensitizers for potentiated anticancer efficacy. Herein, an engineered stem cell-based biotherapy platform (MB/IL12-MSCs) incorporating immune gene plasmid IL12 (pIL12) and photosensitizer methylene blue (MB) is developed to realize tumor-homing delivery of therapeutic agents and photo-immunotherapy efficacy enhancement...
March 2022: Advanced Healthcare Materials
https://read.qxmd.com/read/34714450/current-advances-in-immune-checkpoint-inhibitor-combinations-with-radiation-therapy-or-cryotherapy-for-breast-cancer
#46
REVIEW
Alice Y Ho, Shervin Tabrizi, Samantha A Dunn, Heather L McArthur
PURPOSE: Immune checkpoint inhibition (ICI) has demonstrated clinically significant efficacy when combined with chemotherapy in triple negative breast cancer (TNBC). Although many patients derived benefit, others do not respond to immunotherapy, therefore relying upon innovative combinations to enhance response. Local therapies such as radiation therapy (RT) and cryotherapy are immunogenic and potentially optimize responses to immunotherapy. Strategies combining these therapies and ICI are actively under investigation...
January 2022: Breast Cancer Research and Treatment
https://read.qxmd.com/read/34638817/abscopal-effect-of-radiotherapy-enhanced-with-immune-checkpoint-inhibitors-of-triple-negative-breast-cancer-in-4t1-mammary-carcinoma-model
#47
JOURNAL ARTICLE
Haa-Na Song, Hana Jin, Jung-Hoon Kim, In-Bong Ha, Ki-Mun Kang, Hoon-Sik Choi, Ho-Jin Jeong, Min-Young Kim, Hye-Jung Kim, Bae-Kwon Jeong
Local radiotherapy (RT) is important to manage metastatic triple-negative breast cancer (TNBC). Although RT primarily reduces cancer cells locally, this control can be enhanced by triggering the immune system via immunotherapy. RT and immunotherapy may lead to an improved systemic effect, known as the abscopal effect. Here, we analyzed the antitumor effect of combination therapy using RT with an anti-programmed cell death-1 (PD-1) antibody in primary tumors, using poorly immunogenic metastatic mouse mammary carcinoma 4T1 model...
September 28, 2021: International Journal of Molecular Sciences
https://read.qxmd.com/read/34601286/pi3k%C3%AE-%C3%AE-inhibitor-plus-radiation-enhances-the-antitumour-immune-effect-of-pd-1-blockade-in-syngenic-murine-breast-cancer-and-humanised-patient-derived-xenograft-model
#48
JOURNAL ARTICLE
Min Guk Han, Bum-Sup Jang, Mi Hyun Kang, Deukchae Na, In Ah Kim
INTRODUCTION: We hypothesised that the combined use of radiation therapy and a phosphoinositide 3-kinaseγδ inhibitor to reduce immune suppression would enhance the efficacy of an immune checkpoint inhibitor. METHODS: Murine breast cancer cells (4T1) were grown in both immune-competent and -deficient BALB/c mice, and tumours were irradiated by 3 fractions of 24 Gy. A PD-1 blockade and a phosphoinositide 3-kinase (PI3K)γδ inhibitor were then administered every other day for 2 weeks...
November 2021: European Journal of Cancer
https://read.qxmd.com/read/34530959/2-hexyl-4-pentylenic-acid-hpta-stimulates-the-radiotherapy-induced-abscopal-effect-on-distal-tumor-through-polarization-of-tumor-associated-macrophages
#49
JOURNAL ARTICLE
Wen Hua Duan, Li Ya Jin, Zu Chao Cai, David Lim, Zhi Hui Feng
Objective: The aim of this study was to explore the effects of 2-hexyl-4-pentylenic acid (HPTA) in combination with radiotherapy (RT) on distant unirradiated breast tumors. Methods: Using a rat model of chemical carcinogen (7,12-dimethylbenz[a]anthracene,DMBA)-induced breast cancer, tumor volume was monitored and treatment response was evaluated by performing HE staining, immunohistochemistry, immunofluorescence, qRT-PCR, and western blot analyses. Results: The results demonstrated that HPTA in combination with RT significantly delayed the growth of distant, unirradiated breast tumors...
September 20, 2021: Biomedical and Environmental Sciences: BES
https://read.qxmd.com/read/34525805/three-dimensional-covalent-organic-frameworks-with-cross-linked-pores-for-efficient-cancer-immunotherapy
#50
JOURNAL ARTICLE
Liang Zhang, Lei-Lei Yang, Shu-Cheng Wan, Qi-Chao Yang, Yao Xiao, Hexiang Deng, Zhi-Jun Sun
We report the design and synthesis of a series of three-dimensional (3D) covalent organic frameworks (COFs) as immunogenic cell death (ICD) inducers for cancer immunotherapy. Three triple-topic amine building blocks, inactive to inducing ICD, were used to construct three COFs, COF-607, COF-608, and COF-609, with outstanding ICD eliciting efficiency. Mechanism studies revealed that after linking these ICD inert monomers into the COF backbone, the optical properties of these COFs could be systematically tuned to achieve excellent reactive oxygen species (ROS) production performance...
October 13, 2021: Nano Letters
https://read.qxmd.com/read/34418473/doxorubicin-near-infrared-dye-conjugate-induces-immunogenic-cell-death-to-enhance-cancer-immunotherapy
#51
JOURNAL ARTICLE
Chan Jin, Yan Wang, Yanfeng Li, Jinbo Li, Shuang Zhou, Jiang Yu, Zhaomeng Wang, Yueyang Yu, Haotian Zhang, Dun Wang, Zhonggui He, Yongjun Wang
Cancer immunotherapy often fails to result in a favorable outcome owing to poor activation of immune response, the immunosuppressive tumor microenvironment, and systemic toxicity. In this study, indocyanine green (ICG) was conjugated with doxorubicin (DOX) using a hydrazone linker (DOX-ICG). Results of our in vitro and in vivo studies indicated that DOX-ICG could trigger powerful immunogenic cell death (ICD) of tumor cells. Moreover, its use in combination with immune checkpoint inhibitors could effectively inhibit both primary and abscopal tumors growth and suppress tumor metastasis...
August 19, 2021: International Journal of Pharmaceutics
https://read.qxmd.com/read/34274385/cancer-cell-biomimetic-upconversion-nanoparticles-combining-chemo-photodynamic-therapy-and-cd73-blockade-for-metastatic-triple-negative-breast-cancer
#52
JOURNAL ARTICLE
Feiyang Jin, Jing Qi, Di Liu, Yuchan You, Gaofeng Shu, Yan Du, Jun Wang, Xiaoling Xu, Xiaoying Ying, Jiansong Ji, Yongzhong Du
Photodynamic therapy (PDT) and chemotherapy show clinical promise in destroying orthotopic tumors but are insufficient against abscopal metastases. The research reports the combined application of an anti-CD73 antibody and chemo-PDT to synergistically amplify the anti-metastatic effects of T cell-mediated antitumor immunity. The cancer cell membrane (CM)-cloaked upconversion nanoparticles, integrating rose bengal (RB) and the reactive oxygen species (ROS)-sensitive polymer polyethylene glycol-thioketal-doxorubicin (PEG-TK-DOX, i...
September 10, 2021: Journal of Controlled Release
https://read.qxmd.com/read/34050356/valproic-acid-triggers-radiation-induced-abscopal-effect-by-modulating-the-unirradiated-tumor-immune-microenvironment-in-a-rat-model-of-breast-cancer
#53
JOURNAL ARTICLE
Liya Jin, Wenhua Duan, Zuchao Cai, David Lim, Zhihui Feng
An abscopal effect occurs when localized radiotherapy causes the regression of tumors distant from the irradiated site. However, such a clinically detectable abscopal effect from radiotherapy alone is rare. This study investigated whether valproic acid ([VPA], a histone deacetylase inhibitor [HDACi]) treatment can stimulate radiation-induced abscopal effect. We used 7,12-dimethylbenz[a]anthracene, a typical environmental carcinogen, to establish a rat model with multiple breast tumors. Only one tumor received 8 Gy fractionated doses of X-rays (2 Gy daily fractions over four days) and 200 mg/kg VPA was administered intraperitoneally...
May 28, 2021: Journal of Radiation Research
https://read.qxmd.com/read/34035435/new-clinical-and-biological-insights-from-the-international-targit-a-randomised-trial-of-targeted-intraoperative-radiotherapy-during-lumpectomy-for-breast-cancer
#54
RANDOMIZED CONTROLLED TRIAL
Jayant S Vaidya, Max Bulsara, Michael Baum, Frederik Wenz, Samuele Massarut, Steffi Pigorsch, Michael Alvarado, Michael Douek, Christobel Saunders, Henrik Flyger, Wolfgang Eiermann, Chris Brew-Graves, Norman R Williams, Ingrid Potyka, Nicholas Roberts, Marcelle Bernstein, Douglas Brown, Elena Sperk, Siobhan Laws, Marc Sütterlin, Tammy Corica, Steinar Lundgren, Dennis Holmes, Lorenzo Vinante, Fernando Bozza, Montserrat Pazos, Magali Le Blanc-Onfroy, Günther Gruber, Wojciech Polkowski, Konstantin J Dedes, Marcus Niewald, Jens Blohmer, David McReady, Richard Hoefer, Pond Kelemen, Gloria Petralia, Mary Falzon, David Joseph, Jeffrey S Tobias
BACKGROUND: The TARGIT-A trial reported risk-adapted targeted intraoperative radiotherapy (TARGIT-IORT) during lumpectomy for breast cancer to be as effective as whole-breast external beam radiotherapy (EBRT). Here, we present further detailed analyses. METHODS: In total, 2298 women (≥45 years, invasive ductal carcinoma ≤3.5 cm, cN0-N1) were randomised. We investigated the impact of tumour size, grade, ER, PgR, HER2 and lymph node status on local recurrence-free survival, and of local recurrence on distant relapse and mortality...
August 2021: British Journal of Cancer
https://read.qxmd.com/read/33915224/improving-anti-pd-l1-therapy-in-triple-negative-breast-cancer-by-polymer-enhanced-immunogenic-cell-death-and-cxcr4-blockade
#55
JOURNAL ARTICLE
Minglu Zhou, Chaohui Luo, Zhou Zhou, Lian Li, Yuan Huang
Triple negative breast cancer (TNBC) with highly metastatic features generally does not respond to anti-programmed cell death 1 ligand 1 (PD-L1) therapy due to multiple immunosuppressive mechanisms to exclude and disable T cells. Here, we develop a polymer-based combinatory approach consisting of both immunogenic cell death (ICD)-inducing and CXCR4-inhibiting function to prime tumor microenvironment and improve anti-PD-L1 therapy in TNBC. Our findings revealed that the combination therapy was able to spur the T cell response in primary tumors by increasing the tumor immunogenicity to recruit T cells, removing the physiological barriers of intratumoral fibrosis and collagen to increase T cell infiltration, and reducing the immunosuppressive cells to revive T cells...
June 10, 2021: Journal of Controlled Release
https://read.qxmd.com/read/33867819/macrophage-contributes-to-radiation-induced-anti-tumor-abscopal-effect-on-transplanted-breast-cancer-by-hmgb1-tnf-%C3%AE-signaling-factors
#56
JOURNAL ARTICLE
Lin Zhu, Songling Hu, Qianping Chen, Haowen Zhang, Jiamei Fu, Yuchuan Zhou, Yang Bai, Yan Pan, Chunlin Shao
Objectives: The roles of innate immunity including macrophages in radiation-induced abscopal effect (RIAE) are ambiguous. In this study, we evaluated the role of macrophage in RIAE and the interaction of cytokines in tumor microenvironment after irradiation. Materials and Methods: Transplanted tumor of breast cancer cells in BalB/C mice, severe combined immunodeficiency (SCID) mice and non-obese diabetic (NOD)-SCID mice were irradiated with fractionation doses to observe anti-tumor abscopal effect. The underlying mechanism of RIAE was investigated by treating the mice with TNF-α inhibitor or macrophage depletion drug and analyzing the alteration of macrophage distribution in tumors...
2021: International Journal of Biological Sciences
https://read.qxmd.com/read/33857366/abscopal-effect-after-palliative-five-fraction-radiation-therapy-on-bone-and-lymph-node-metastases-from-luminal-b-breast-cancer-a-case-report-and-clinical-implications-for-palliative-radiation-therapy
#57
JOURNAL ARTICLE
Tae Hyung Kim, Jee Suk Chang
The abscopal effect is a phenomenon in which radiation therapy results in the regression of metastatic lesions at a distance from the irradiated lesions. Here, we have described a 37-year-old woman with advanced luminal B breast cancer who presented with severe pain at multiple sites. Multiple bone, lymph node, and lung metastases were found on computed tomography (CT). She refused to receive any systemic therapy, but she agreed to receive palliative radiotherapy (RT). Multi-site RT (25 or 30 Gy in 5 fractions) was performed for pain palliation...
April 16, 2021: Radiation Oncology Journal
https://read.qxmd.com/read/33657951/local-hyperthermia-combined-with-ctla-4-blockade-induces-both-local-and-abscopal-effects-in-a-murine-breast-cancer-model
#58
JOURNAL ARTICLE
Yoriko Ibuki, Yutaka Takahashi, Keisuke Tamari, Kazumasa Minami, Yuji Seo, Fumiaki Isohashi, Masahiko Koizumi, Kazuhiko Ogawa
PURPOSE: To evaluate the antitumor efficacy in local and distant tumors induced by local hyperthermia with CTLA-4 blockade. METHODS: A mouse breast cancer cell line was inoculated into both sides of the legs of mice. The mice were treated with three administrations of CTLA-4 blockade, a single application of local hyperthermia (42.5 °C for 20 min) to the tumor on one side of the leg, or the combination of the two. Tumor growth in locally heated tumors (HT tumors) and unheated distant tumors (UnHT tumors) and overall survival were evaluated...
2021: International Journal of Hyperthermia
https://read.qxmd.com/read/33642128/pi3k%C3%AE-%C3%AE-inhibitor-combined-with-radiation-enhances-the-antitumor-immune-effect-of-anti-pd1-in-a-syngeneic-murine-triple-negative-breast-cancer-model
#59
JOURNAL ARTICLE
Won Ick Chang, Min Guk Han, Mi Hyun Kang, Ji Min Park, Eric Eunshik Kim, Junhyung Bae, Soyeon Ahn, In Ah Kim
PURPOSE: The poor response of breast cancer to immune checkpoint blockade might result from low immunogenicity and the immune-suppressive tumor microenvironment. We hypothesized that in situ tumor vaccination via radiation therapy (RT) and suppression of immune tolerance via phosphoinositide 3-kinase δ (PI3Kδ) inhibition would enhance the efficacy of immune checkpoint blockade. METHODS AND MATERIALS: 4T1 murine breast cancer cells were grown in both immune-competent and -deficient BALB/c mice, and tumors were irradiated with 24 Gy in 3 fractions...
February 25, 2021: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/33457077/gas-plasma-irradiation-of-breast-cancers-promotes-immunogenicity-tumor-reduction-and-an-abscopal-effect-in-vivo
#60
JOURNAL ARTICLE
Hamed Mahdikia, Fariba Saadati, Eric Freund, Udo S Gaipl, Keivan Majidzadeh-A, Babak Shokri, Sander Bekeschus
While many new and emerging therapeutic concepts have appeared throughout the last decades, cancer still is fatal in many patients. At the same time, the importance of immunology in oncotherapy is increasingly recognized, not only since the advent of checkpoint therapy. Among the many types of tumors, also breast cancer has an immunological dimension that might be exploited best by increasing the immunogenicity of the tumors in the microenvironment. To this end, we tested a novel therapeutic concept, gas plasma irradiation, for its ability to promote the immunogenicity and increase the toxicity of breast cancer cells in vitro and in vivo...
December 29, 2020: Oncoimmunology
keyword
keyword
81344
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.